- Report
- November 2023
- 190 Pages
Global
From €4471EUR$4,500USD£3,717GBP
- Report
- November 2023
- 190 Pages
Global
From €4471EUR$4,500USD£3,717GBP
- Report
- November 2023
- 182 Pages
Global
From €4471EUR$4,500USD£3,717GBP
- Report
- October 2023
- 71 Pages
India
From €3477EUR$3,500USD£2,891GBP
- Report
- October 2023
- 190 Pages
Global
From €4471EUR$4,500USD£3,717GBP
- Report
- October 2023
- 189 Pages
Global
From €4471EUR$4,500USD£3,717GBP
- Report
- October 2023
- 190 Pages
Global
From €4471EUR$4,500USD£3,717GBP
- Report
- October 2023
- 181 Pages
Global
From €4471EUR$4,500USD£3,717GBP
- Report
- October 2023
- 189 Pages
Global
From €4471EUR$4,500USD£3,717GBP
- Report
- October 2023
- 178 Pages
Global
From €4471EUR$4,500USD£3,717GBP
- Report
- September 2023
- 88 Pages
Israel
From €3477EUR$3,500USD£2,891GBP
- Report
- October 2023
- 89 Pages
Japan
From €3477EUR$3,500USD£2,891GBP
- Report
- January 2022
- 60 Pages
Global
From €2747EUR$2,765USD£2,284GBP
€3924EUR$3,950USD£3,263GBP
- Report
- March 2022
- 120 Pages
Global
From €2484EUR$2,500USD£2,065GBP
- Report
- March 2022
- 120 Pages
Global
From €2484EUR$2,500USD£2,065GBP
- Report
- November 2023
- 161 Pages
Global
From €2484EUR$2,500USD£2,065GBP
- Report
- October 2023
- 166 Pages
Global
From €2484EUR$2,500USD£2,065GBP
- Report
- September 2023
- 168 Pages
Global
From €2484EUR$2,500USD£2,065GBP
- Report
- March 2022
- 120 Pages
Global
From €2484EUR$2,500USD£2,065GBP
- Report
- January 2022
- 120 Pages
Global
From €2484EUR$2,500USD£2,065GBP
The Gastrointestinal Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat diseases and disorders of the gastrointestinal tract. These drugs are used to treat conditions such as irritable bowel syndrome, Crohn's disease, ulcerative colitis, and gastroesophageal reflux disease. Commonly prescribed drugs include antacids, proton pump inhibitors, and H2 receptor antagonists.
The Gastrointestinal Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Pfizer, GlaxoSmithKline, Merck & Co., AstraZeneca, and Novartis. These companies are constantly developing new drugs and treatments to meet the needs of patients. Show Less Read more